Kailera Therapeutics, Inc. (KLRA): SCHEDULE 13D filed Apr 23, 2026

Form type

SCHEDULE 13D

Filing date

Apr 23, 2026

Accession number

0001193125-26-174293

Filer

Kailera Therapeutics, Inc. (CIK 2096997)